Dataset Information


Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis.



KRAS gene mutations can predict prognosis and treatment response in patients with metastatic colorectal cancer (mCRC).


We undertook a meta-analysis of three randomized, placebo-controlled trials (RECOURSE, TERRA and J003) to investigate the impact of KRAS mutations in codons 12 or 13 on overall survival (OS) and progression-free survival in patients receiving trifluridine/tipiracil (FTD/TPI) for refractory mCRC.


A total of 1375 patients were included, of whom 478 had a KRAS codon 12 mutation and 130 had a KRAS codon 13 mutation. In univariate analyses, the absence of a KRAS codon 12 mutation was found to significantly increase the OS benefit of FTD/TPI relative to placebo compared with the presence of the mutation {hazard ratio (HR), 0.62 [95% confidence interval (CI): 0.53-0.72] versus 0.86 (0.70-1.05), respectively; interaction P = 0.0206}. Multivariate analyses showed that taking confounding factors into account reduced the difference in treatment effect between the presence and the absence of KRAS codon 12 mutations, confirming that treatment benefit was maintained in patients with [HR, 0.73 (95% CI: 0.59-0.89)] and without [HR, 0.63 (95% CI: 0.54-0.74)] codon 12 mutations (interaction P = 0.2939). KRAS mutations in codon 13 did not reduce the OS benefit of FTD/TPI relative to placebo, and, furthermore, KRAS mutations at either codon 12 or codon 13 did not affect the progression-free survival benefit.


Treatment with FTD/TPI produced a survival benefit, relative to placebo, regardless of KRAS codon 12 or 13 mutation status in patients with previously treated mCRC.

PROVIDER: S-EPMC9271514 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8253956 | BioStudies
2018-01-01 | S-EPMC6240219 | BioStudies
| S-EPMC8205879 | BioStudies
| S-EPMC6802061 | BioStudies
| S-EPMC7154008 | BioStudies
| S-EPMC7765280 | BioStudies
| S-EPMC8239287 | BioStudies
| S-EPMC8649060 | BioStudies
| S-EPMC8453191 | BioStudies
| S-EPMC7606042 | BioStudies